|
|||||
|
|
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic‐phase CML in clinical practice: 3‐year European SIMPLICITY data |
|
| Authors: | Carlo Gambacorti‐Passerini,Clara Chen,Catherine Davis,Ginny P. Sen,Christy Guyan,Rü diger Hehlmann,Mauricette Michallet,Ronald Paquette,Stuart L. Goldberg |
| Abstract: | |
| Keywords: | dasatinib imatinib mesylate leukemia chronic BCR‐ABL positive myeloid chronic‐phase observational studies |